Completed
Vortioxetine for Post-COVID-19 Condition
NCT05047952
- Conditions
- Behavior, Behavioral Symptoms, COVID-19, +27 more
- Locations
-
- Brain and Cognition Discovery Foundation (BCDF) Toronto, Ontario, Canada